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Abstract 43 
Neuropeptides that act as muscle relaxants have been identified in chordates and 44 
protostomian invertebrates but little is known about the molecular identity of neuropeptides that act 45 
as muscle relaxants in deuterostomian invertebrates (e.g. echinoderms) that are “evolutionary 46 
intermediates” of chordates and protostomes. Here we have used the apical muscle of the starfish 47 
Patiria pectinifera to assay for myorelaxants in extracts of this species. A hexadecapeptide with the 48 
amino acid sequence Phe-Gly-Lys-Gly-Gly-Ala-Tyr-Asp-Pro-Leu-Ser-Ala-Gly-Phe-Thr-Asp was 49 
identified and designated starfish myorelaxant peptide (SMP). Cloning and sequencing of a cDNA 50 
encoding the SMP precursor protein revealed that it comprises 12 copies of SMP as well as 3 51 
peptides (7 copies in total) that are structurally related to SMP. Analysis of the expression of SMP 52 
precursor transcripts in P. pectinifera using qPCR revealed the highest expression in the radial 53 
nerve cords and lower expression levels in a range of neuromuscular tissues, including the apical 54 
muscle, tube feet and cardiac stomach. Consistent with these findings, SMP also caused relaxation 55 
of tube foot and cardiac stomach preparations. Furthermore, SMP caused relaxation of apical 56 
muscle preparations from another starfish species - Asterias amurensis. Collectively, these data 57 
indicate that SMP has a general physiological role as a muscle relaxant in starfish. Interestingly, 58 
comparison of the sequence of the SMP precursor with known neuropeptide precursors revealed 59 
that SMP belongs to a bilaterian family of neuropeptides that include molluscan pedal peptides (PP) 60 
and arthropodan orcokinins (OK). This is the first study to determine the function of a PP/OK-type 61 
peptide in a deuterostome.  62 
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Introduction 63 
A variety of neuropeptides that act as smooth muscle relaxants in vertebrates have been 64 
identified, including calcitonin-gene related peptide (CGRP), adrenomedullin, corticotropin-65 
releasing hormone (CRH), urocortin, vasoactive intestinal peptide (VIP), pituitary adenylyl 66 
cyclase-activating peptide (PACAP) and peptide histidine isoleucine (PHI) (Kitamura et al. 1993; 67 
Brain et al. 1985; Williams et al. 1987; Schilling et al. 1998; Grider & Makhlouf 1986; Miyata et 68 
al. 1989; Robberecht et al. 1982). Likewise, studies on protostomian invertebrates such as insects 69 
have identified a number of myoinhibitory neuropeptides; for example, type-A allatostatins, type-B 70 
allatostatins or myoinhibitory peptides (MIPs) and myosupressins (Bendena et al. 1997; Blackburn 71 
et al. 1995; Holman et al. 1986). In the context of our understanding of the evolutionary history 72 
and relationships of neuropeptides in the animal kingdom (Mirabeau & Joly 2013), it appears that 73 
neuropeptides belonging to different families have been recruited to act as muscle relaxants in 74 
vertebrates and protostomes. It is of interest, therefore, to identify neuropeptides that act as muscle 75 
relaxants in animals that occupy an “intermediate” position with respect to the vertebrates and 76 
protostomes in animal phylogeny – the deuterostomian invertebrates, which include two chordate 77 
sub-phyla that are closely related to vertebrates (Urochordata and Cephalochordata) and the 78 
Ambulacraria (Hemichordata and Echinodermata) (Adoutte et al. 2000). 79 
Nothing is known about the molecular identity of neuropeptides that act as muscle relaxants 80 
in hemichordates but neuropeptides that act as muscle relaxants have been identified in 81 
echinoderms – the SALMFamides. The prototypes for this family of neuropeptides were both 82 
identified in the starfish Asterias rubens and Asterias forbesi – S1 (GFNSALMF-NH2) and S2 83 
(SGPYSFNSGLTF-NH2) (Elphick et al. 1991a; Elphick et al. 1991b). In vitro pharmacological 84 
tests with S1 and S2 revealed that both peptides cause relaxation of neuromuscular preparations 85 
from A. rubens – the cardiac stomach, tube feet and apical muscle – but with S2 more 86 
potent/effective than S1 (Elphick & Melarange 2001; Elphick et al. 1995; Melarange & Elphick 87 
2003; Melarange et al. 1999). Subsequently, other members of the SALMFamide neuropeptide 88 
family were identified in other echinoderms (e.g. sea cucumbers) and these peptides were also 89 
found to act as muscle relaxants (Diaz-Miranda & Garcia-Arraras 1995; Ohtani et al. 2002). 90 
It is unlikely that SALMFamides are the only family of neuropeptides that act as muscle 91 
relaxants in echinoderms, given the multitude of neuropeptides that have been found to act as 92 
muscle relaxants in vertebrates and protostomian invertebrates (see above). Therefore, here we set 93 
out to employ use of an in vitro muscle bioassay to screen for muscle relaxants in an echinoderm. 94 
The starfish species Patiria pectinifera was selected as a model system because it is widely 95 
distributed in the northern Pacific Ocean, and can be easily collected and transported as it found in 96 
shallow coastal waters. This species adapts well to artificial conditions in the laboratory and as a 97 
non-specialized predator and/or scavenger it can be fed on algae, detritus and small invertebrates. 98 
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For these reasons, this species has been used in many scientific studies as a model organism for 99 
studying starfish physiology, and it is also of interest from both economic and environmental 100 
perspectives (Dan-Sohkawa et al. 1986; Davydov et al. 1990; Ikegami et al. 1967; Jo et al. 2013; 101 
Mita et al. 2009; Haraguchi et al. 2015). The apical muscle of P. pectinifera was selected as a 102 
bioassay because it can be easily dissected from the aboral body wall of the arms in this species. 103 
Furthermore, as highlighted above, previous studies have revealed that SALMFamides cause 104 
relaxation of the apical muscle from the starfish A. rubens (Melarange & Elphick 2003). 105 
Here we report the isolation of a novel neuropeptide from P. pectinifera that causes 106 
relaxation of the apical muscle from this species - starfish myorelaxant peptide (SMP). A cDNA 107 
encoding the SMP precursor protein was cloned and sequenced, enabling investigation of its 108 
expression pattern in P. pectinifera and investigation of relationships with neuropeptides that have 109 
been identified in other echinoderms and other phyla.  110 
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Methods 111 
 112 
Animals 113 
Live specimens of the starfish species Patiria pectinifera (Fig. 1A and B) and Asterias 114 
amurensis were collected at Cheongsapo of Busan, Korea, and maintained in a recirculating 115 
seawater system at 15 oC until use. The animals were fed once every three days with live manila 116 
clam, Ruditapes philippinarum. Live specimens of the starfish species Asterias rubens were 117 
collected at low tide from the Thanet coast of Kent in the UK, and maintained in a recirculating 118 
seawater system at 12 oC until use. The animals were fed weekly with live mussels (Mytilus edulis). 119 
 120 
Peptide extraction 121 
Starfish (P. pectinifera) were cut into pieces using scissors, soaked in 70% methanol and 122 
then heated in a double boiler for 5 min to denature proteins and inhibit proteolytic enzyme activity. 123 
The boiled sample was cooled on ice and then homogenized (PT10-35, Kinematica, Inc., 124 
Switzerland), followed by addition of glacial acetic acid to yield a final concentration of 5% acetic 125 
acid. The homogenate was then centrifuged (10,000 × g, 40 min, 4 oC). The pellet was re-extracted 126 
in 5% acetic acid with same extraction method. The supernatant was pooled and concentrated 127 
using a rotary evaporator. The concentrated solution was diluted with 10 volumes of ethanol and 128 
then the suspension was centrifuged (10,000 × g, 40 min, 4 oC) to remove the precipitate. The 129 
supernatant was evaporated to 100 mL, and then 100 mL of ethanol with 1.1 g sodium chloride 130 
was added to it. After centrifugation to remove precipitate, the supernatant was concentrated by 131 
evaporation, and 0.1 volume of 1 N hydrochloride was added. The precipitate was removed again 132 
by centrifugation (20,000 × g, 50 min, 4 oC) and the supernatant was applied to a C18 cartridge 133 
(Sep-pak C18; Waters Corp). The column was washed with 10% methanol/0.1% trifluoroacetic 134 
acid (TFA) and retained materials were then eluted with 60% methanol/0.1% TFA. The eluate was 135 
evaporated and its biological activity on the apical muscle of P. pectinifera was investigated, as 136 
described below in the methods section for in vitro bioassay and pharmacology. 137 
 138 
Peptide purification 139 
The 60% methanol elutate was applied to a cation-exchange column (CM-52, 2.5 cm × 30 140 
cm, Whatman, Oregon, USA), and eluted with a linear gradient of 0.02 to 1.5 M ammonium 141 
acetate (pH 5.0) for 6 hours at a flow rate of 2.75 ml/min. Absorbance peaks were monitored at 254 142 
nm (ISCO Model UA-6 detector, Nebraska, USA) and fractions were collected every 4 min. The 143 
bioactive fractions, which eluted between fraction numbers 40 to 45, were pooled and then 144 
subjected to reversed phase (RP)-HPLC (Vydac 218TP510 Protein & Peptide C18, 9.2 mm x 145 
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250mm, USA). Elution was performed with a linear gradient of 0 to 60% acetonitrile/0.1% TFA at 146 
a flow rate of 3.0 ml/min for 120 min, and fractions were collected every 2 min. 147 
Bioactive fractions eluted between 50 and 54 min with RP-HPLC and these were subjected 148 
to further purification steps using an anion-exchange column (TSKgel DEAE-5PW, 7.5 × 75 mm, 149 
Tosho) with a linear gradient of 0 to 0.5 M sodium chloride in 10 mM Tris-HCl (pH 9.2) at a flow 150 
rate of 0.5 ml/min for 100 min. A fraction that eluted with a concentration of about 0.1 M sodium 151 
chloride from the anion-exchange column caused relaxation of the apical muscle from P. 152 
pectinifera. This eluate was subjected to further RP-HPLC (Capcellpak C18, 4.6 × 250 mm, 153 
Shisheido). The absorbance peaks were recovered with a linear gradient of 15 to 30% 154 
acetonitrile/0.1% TFA at flow rate of 1 ml/min for 60 min. The bioactive peak was then subjected 155 
again to RP-HPLC using the same solvent gradient as in the previous RP-HPLC step but with a 156 
different column (Hypersil-BDS C18, 2 × 125 mm, HP). Finally, the active peak was applied to the 157 
same column as in the previous step but with an isocratic elution of 20% acetonitrile/0.1% TFA at a 158 
flow rate of 0.5 ml/min. 159 
 160 
Structure determination and synthesis of peptides 161 
To determine the molecular mass and amino acid sequence of the purified starfish 162 
myorelaxant peptide (SMP), it was analyzed using an automated N-terminal amino acid gas-phase 163 
sequencer (PSQ-1, Shimadzu) and a MALDI-TOF mass spectrometer (Voyager-DETM PRO 164 
spectrometer, Perseptive Biosystem). On the basis of the structural determination results, two 165 
peptides, with or without the carboxyl-terminus amidated, were automatically synthesized by a 166 
conventional solid-phase method with Fmoc-protected amino acids and coupling reagents, 1-167 
hydroxybenzotriazole (HOBT) and N,N-diisopropylcarbodimide (DIPCI), using a peptide 168 
synthesizer (PSSM-8, Shimadzu) as described previously (Kim et al. 2015). Other neuropeptides, 169 
S1 (GFNSALMFamide), S2 (SGPYSFNSGLTFamide), FMRFamide, and FLRFamide were 170 
synthesized to enable comparison of their activities with that of the identified peptide. 171 
 172 
In vitro bioassay and pharmacology 173 
Three neuromuscular preparations, apical muscle, cardiac stomach and tube feet, were 174 
dissected from P. pectinifera for in vitro bioassay and pharmacology according to a slightly 175 
modified version of previously reported methods (Elphick et al. 1995; Melarange & Elphick 2003). 176 
Synthetic neuropeptides were also tested for bioactivity on apical muscle preparations from a 177 
different starfish species - A. amurensis. Briefly, the apical muscle was cut from the aboral body 178 
wall of an arm, where the apical muscle forms a thickening of longitudinally orientated muscle that 179 
runs along the mid-line of the inner side (Fig. 1C). A piece of cardiac stomach between the oral 180 
opening and extrinsic retractor strand was obtained by removing the aboral body wall from the 181 
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central disk and the proximal region. An individual whole tube foot was dissected from the arm 182 
ambulacra but without the ampulla. All muscle preparations were cut to approximately 10 mm, and 183 
both ends of the muscle preparations were tied with cotton threads. The preparations were then 184 
suspended vertically in a 2 ml polypropylene chamber containing artificial seawater (ASW) with 185 
aeration, one end being connected to silver hook on the bottom of the chamber and the other to a 186 
force displacement transducer (Type 45196A, NEC-Sanei Instrument Ltd., Tokyo, Japan). Output 187 
from the force displacement transducer was monitored by a recorder (WR7300, GRAPHTEC 188 
CORP., Yokohama, Japan) via an amplifier (AS1302, NEC-Sanei, Tokyo, Japan), which recorded 189 
the mechanical responses of the device. Prior to testing, the muscle preparations were allowed to 190 
stabilize for about 90 min. The resting tension was then adjusted to 1.0 g for apical muscle and 0.5 191 
g for cardiac stomach and tube foot. Muscles in the chamber were allowed to equilibrate for about 192 
30 min in ASW, during which time the ASW in the chamber was freshly replaced every 15 min. 193 
Pre-contraction of apical muscle, cardiac stomach or tube foot preparations was induced by 194 
applying 1 μM acetylcholine (ACh), 10 μM carbachol or 30 mM high-potassium ASW, 195 
respectively. Then immediately after equilibration, the muscles were treated with test samples to 196 
measure relaxation responses. 197 
The bioassay system adopted for monitoring purification of the bioactive peptide was a 198 
system that measures relaxation of apical muscle from P. pectinifera pre-contracted for 2 min at 20 199 
min intervals with 1 μM ACh. An aliquot of each test fraction was evaporated to dryness, dissolved 200 
with 50 μl of phosphate buffer saline (PBS), and added into the chamber. 201 
At least 4 separate experiments to test the pharmacological activities of synthetic SMP, C-202 
terminally-amidated SMP (SMPamide) and other neuropeptides were performed, using a 203 
concentration range of 10-10 M to 10-5 or 10-4 M at room temperature. EC50 values represent the 204 
concentration of peptide required to cause a response 50% of the maximum. The maximal response 205 
(Emax) was expressed as the percentage of the maximal relaxation induced by 10-4 or 10-5 M of each 206 
peptide compared to the maximal contraction of apical muscle by 1 μM ACh, of cardiac stomach 207 
by 10 μM carbacol or of tube foot by 30 mM high-potassium ASW. The relative activity was 208 
calculated as the ratio of the concentration of SMP or other peptides required to produce responses 209 
equivalent to a half-maximal response. 210 
 211 
cDNA cloning and sequence analysis 212 
Total RNA was extracted using RNeasy Mini kit (Qiagen, USA) from total tissues (except 213 
body wall) of P. pectinifera, and then mRNA was purified using Oligotex mRNA mini kit (Qiagen, 214 
USA) following the manufacturer’s instructions. The synthesis rapid amplification cDNA end 215 
(RACE)-ready cDNA template was performed with SMARTer™ RACE cDNA amplification Kit 216 
(Clontech, UK) according to manufacturer’s instructions. 217 
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Based on the amino acid sequence of the purified peptide, two degenerate primers were 218 
designed for 3’ RACE PCR, and then 5’ RACE PCRs were conducted with sequence-specific 219 
primers designed from the sequencing result of the 3’ RACE product. The sequences of primers 220 
used in RACE are listed in Table S1. The first PCR conditions for 3’ RACE included initial 221 
denaturation at 94 °C for 3 min followed by: 5 cycles of 94 °C for 1 min, 59 °C for 1 min, and 222 
72 °C for 1 min; 5 cycles of 94 °C for 1 min, 57 °C for 1 min, and 72 °C for 1 min; 20 cycles of 223 
94 °C for 1 min, 55 °C for 1 min, and 72 °C for 1 min. Nested PCR for 3’RACE was performed 224 
with the same conditions as the first PCR. The first PCR product of 5’ RACE was obtained by the 225 
following thermal cycle profile: 5 cycles of 94 °C for 30 sec, 67 °C for 30 sec, and 72 °C for 1 min; 226 
5 cycles of 94 °C for 30 sec, 65 °C for 30 sec, and 72 °C for 1 min; 25 cycles of 94 °C for 30 sec, 227 
63 °C for 30 sec, and 72 °C for 1 min. Nested PCR for 5’ RACE was as follows: 5 cycles of 94 °C 228 
for 30 sec, 69 °C for 30 sec, and 72 °C for 1 min; 5 cycles of 94 °C for 30 sec, 67 °C for 30 sec, 229 
and 72 °C for 1 min; 25 cycles of 94 °C for 30 sec, 65 °C for 30 sec, and 72 °C for 1 min. 230 
PCR products in the last step of 3’ and 5’ RACE were introduced into the pGEM-Teasy 231 
vector system (Promega Corporation, USA) and sequenced. The full-length translated sequence of 232 
the SMP precursor, based on the cloned cDNA nucleotide sequence, was aligned by BLAST 233 
(http://blast.ncbi.nlm.nih.gov/blast.cgi) and the sequence was submitted to the GenBank database 234 
(Accession number: KT870152). Multiple sequence alignment of the full-length P. pectinifera 235 
SMP precursor and related proteins in other species was performed using Clustal Omega 236 
(http://www.ebi.ac.uk/Tools/msa/clustalo/). 237 
Asterias rubens radial nerve cord transcriptome sequence data obtained by Illumina HiSeq 238 
sequencing, as reported previously (Semmens et al. 2013), was analysed using BLAST to identify 239 
a homolog of the P. pectinifera SMP precursor. Using the sequence of the P. pectinifera SMP 240 
precursor as a query, a 444 bp A. rubens contig (1025452) comprising a partial sequence 241 
corresponding to the 3’ region of the P. pectinifera SMP precursor cDNA was identified. Then 242 
ovarian transcriptome sequence data obtained from multiple echinoderm species ((Reich et al. 243 
2015); http://www.echinobase.org/Echinobase/Blasts) was analysed and non-overlapping contigs 244 
encoding the 5’ region (GAUS01027726.1) and the 3’ region (GAUS01027727.1) of a SMP-type 245 
precursor transcript was identified from the starfish species Asterias forbesi. Combining these 246 
partial sequence data from A. rubens and A. forbesi, primers were designed to enable PCR 247 
amplification of the full-length SMP precursor coding sequence from A. rubens, as described below. 248 
Total RNA was extracted from radial nerve cords of A. rubens using the SV Total RNA 249 
Isolation System according to the manufacturer’s instructions (Promega). Then cDNA was 250 
synthesized using the QuantiTect Rev. Transcription Kit in accordance with the manufacturer’s 251 
instructions (QIAgen). A cDNA containing the coding sequence of the A. rubens SMP-type 252 
precursor was amplified by PCR using Phusion high-fidelity PCR master mix (NEB) and the oligo 253 
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primers 5’-ATGCGGCTCATCATGCAC-3’ and 5’-TACACACCAAGCAGTGACA-3’. The 254 
conditions for PCR included initial denaturation at 98 °C for 2 min followed by: 30 cycles of 98 °C 255 
for 10 sec, 55 °C for 30 sec, 72 °C for 1 min, 72 °C for 8 min and hold at 4 °C. 1% gel 256 
electrophoresis was performed to analyse the PCR products and then the PCR product was gel-257 
extracted and purified using a QIAquick gel extraction kit (QIAgen). Zero Blunt TOPO PCR 258 
cloning kit (Invitrogen) was used to ligate the PCR product into the pCR-Blunt II with TOPO 259 
vector for sequencing. The sequence obtained (GenBank accession number KT870153) was 260 
translated into protein sequence using ExPASy (http://web.expasy.org/translate/) and SignalP 4.1 261 
(http://www.cbs.dtu.dk/services/SignalP/) was used to predict the signal peptide of the translated 262 
protein sequence. 263 
 264 
Real time-quantitative PCR (RT-qPCR) analysis 265 
To quantitatively analyse expression of SMP precursor transcripts in different starfish 266 
tissues/organs, RT-qPCR was employed using a LightCycler 480 Real-Time PCR System (Roche, 267 
Germany) with LightCycler 480 SYBR green master I (Roche, Germany). Total RNA extracted 268 
from the apical muscle, radial nerve cord, cardiac stomach, pyloric stomach, coelomic lining 269 
containing transverse muscles, tube feet, pyloric caecae, testis, and ovary were obtained from five 270 
specimens of P. pectinifera. cDNA was synthesized using the TOPscript cDNA synthesis Kit with 271 
oligo dT (dT18) (Enzynomics, Korea) according to the manufacturer's instructions. The primer 272 
pairs used for amplifying SMP precursor cDNA and elongation factor 1α (EF1α) cDNA as a 273 
control for normalization were SMP RT-F and SMP RT-R, and EF1α RT-F and EF1α RT-R, 274 
respectively (see Table S1 for sequences). Based on the standard curves for both SMP and EF1α, 275 
the relative expression levels of SMP transcripts in each tissue were normalized against the level of 276 
the EF1α control using the following formula: relative 277 
expression = [(1 + ESMP)CP_SMP]−1/[(1 + EEF1α)CP_EF1α] −1, in which E is PCR efficiency 278 
(E = 10−1/slope − 1) and CP is the threshold cycle number. Triplicate amplifications were carried out 279 
independently, and the relative quantification results were expressed as the fold levels of SMP 280 
precursor transcripts. Statistical analysis of the data for comparison between tissues was carried out 281 
by one-way ANOVA, followed by Duncan’s Multiple Range test, using the SPSS 21 program. P 282 
values with p < 0.05 were considered statistically significant.  283 
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Results 284 
 285 
Purification of a novel hexadecapeptide that relaxes the apical muscle of P. pectinifera 286 
 A whole-body extract of P. pectinifera induced relaxation of apical muscle pre-contracted 287 
with ACh (Fig. 1D), indicating that it was an appropriate source to isolate myorelaxants. A single 288 
absorbance peak (peak A) containing a myorelaxant was successfully purified from the whole-289 
body extract through six steps of column purification which sequentially were cation, repeated RP, 290 
and anion HPLC. Finally, peak A was isocratically eluted with 20% acetonitrile/0.1% TFA at 16.1 291 
min of the retention time (Fig. 2A). An aliquot of peak A relaxed the apical muscle of P. 292 
pectinifera that was pre-contracted by ACh (Fig. 2B). Purified peak A was identified as a sixteen-293 
residue peptide with the sequence Phe-Gly-Lys-Gly-Gly-Ala-Tyr-Asp-Pro-Leu-Ser-Ala-Gly-Phe-294 
Thr-Asp with a free carboxy terminus based on N-terminal amino acid sequencing and molecular 295 
mass analysis (Fig. 2C and Figure S1A). The purified hexadecapeptide was designated starfish 296 
myorelaxant peptide (SMP). To confirm the primary structure and chemical properties of SMP 297 
under RP-HPLC, SMP with a free carboxy terminus (SMP) and SMP with an amidated carboxy 298 
terminus (SMPamide) were synthesized. The synthetic SMP and native SMP eluted with an 299 
identical retention time, and a mixture of the two peptides eluted as a single peak under RP-HPLC 300 
(Fig. 2D). Moreover, SMP and SMPamide did not have an identical retention time on RP-HPLC 301 
(Figure S1B). Collectively, the results demonstrate that the purified SMP is the hexdecapeptide 302 
Phe-Gly-Lys-Gly-Gly-Ala-Tyr-Asp-Pro-Leu-Ser-Ala-Gly-Phe-Thr-Asp-OH, with a free carboxy 303 
terminus and without any post-translational modifications. 304 
 305 
SMP is a potent relaxant of P. pectinifera apical muscle in vitro 306 
SMP and a C-terminally amidated analog of SMP (SMPamide) both caused dose-dependent 307 
relaxation of in vitro apical muscle preparations from P. pectinifera (Fig. 2E). The threshold 308 
response, ED50 and Emax for SMP were 10-10 M, 6.0 × 10-8 M and 120.02±7.00 % and for 309 
SMPamide were 10-10 M and 4.0 × 10-8 M and 134.69±9.57 %, respectively (Fig. 2E). These results 310 
corroborate the structural determination that SMP is not C-terminally amidated and does not 311 
required C-terminal modification for its bioactivity. Comparison of the bioactivity of SMP with the 312 
starfish SALMFamide neuropeptides S1 and S2 revealed that SMP was more potent/efficacious 313 
than these peptides as a relaxant of the apical muscle from P. pectinifera (Fig. 2E). Thus, the Emax 314 
for S1 and S2 at a concentration of 10-5 M were only 44.15±2.41 and 29.72±8.29, respectively. 315 
Furthermore, the molluscan neuropeptides FLRFamide and FMRFamide, which share some 316 
sequence similarity with SALMFamides, exhibited little or no bioactivity as relaxants of apical 317 
muscle preparations, even at concentrations as high as 10-5 M (Fig. 2E). 318 
 319 
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The P. pectinifera SMP precursor protein comprises twelve copies of SMP and seven copies 320 
of other SMP-like peptides 321 
A cDNA encoding the P. pectinifera SMP precursor was cloned and sequenced (GenBank 322 
accession number: KT870152) and the nucleotide sequence and the deduced protein sequence are 323 
shown in Fig. 3. The cDNA sequence comprised 1682 bp, starting with a 5’ untranslated region 324 
(UTR) of 148 bp, followed by an open reading frame (ORF) of 1281 bp, a 3’ UTR of 253 bp 325 
including a poly-A tail. The ORF of the SMP precursor encodes a 426 amino acid residue protein. 326 
that contains four regions: a signal peptide (Met1-Ala19), as predicted by SignalP 4.1 327 
(http://www.cbs.dtu.dk/services/SignalP/), a N-terminal spacer peptide (Ser20-Arg56) containing 328 
several acidic amino acids, a region containing twelve copies of SMP and seven copies of SMP-329 
like peptides with each peptide copy bounded by dibasic cleavage sites (Phe57-Arg402) and a C-330 
terminal region (Thr403-Arg426). 331 
 332 
SMP transcripts are widely expressed in P. pectinifera and SMP causes in vitro relaxation of 333 
other muscle preparations from P. pectinifera 334 
The relative expression levels of the SMP precursor mRNA in different tissues (apical 335 
muscle, radial nerve cord, cardiac stomach, pyloric stomach, coelomic lining, tube feet, pyloric 336 
caecae, testis, and ovary) were determined by RT-qPCR (Fig. 4A). The highest expression of SMP 337 
transcripts was detected in radial nerve cords, which are the major components of the nervous 338 
system in starfish. In addition, relatively high expression levels of SMP transcripts were observed, 339 
in descending order, in apical muscle, tube feet, coelomic lining, cardiac stomach, pyloric stomach 340 
and pyloric caecae. However, expression of SMP transcripts in reproductive organs (ovary and 341 
testis) was barely detectable. These findings indicate that SMP is a neuropeptide and suggest that 342 
SMP may have widespread roles as a regulator of muscle activity in P. pectinifera. To address this 343 
issue, SMP was tested in vitro on two other neuromuscular preparations in which SMP transcripts 344 
are detected –cardiac stomach and tube feet. SMP caused dose-dependent relaxation of both 345 
preparations and, as with apical muscle preparations, SMP was more potent/effective as a muscle 346 
relaxant than the SALMFamides S1 and S2 (Fig. 4B, C). 347 
 348 
SMP causes relaxation of apical muscle preparations from the starfish Asterias amurensis and 349 
identification of an SMP-type precursor in Asterias rubens 350 
Having identified SMP as a muscle relaxant in P. pectinifera, we then investigated if this 351 
peptide also acts as a muscle relaxant in other starfish species. To address this issue we tested 352 
synthetic SMP on apical muscle preparations from A. amurensis. SMP caused dose-dependent 353 
relaxation and the Emax was 82.1±1.94 % at a concentration of 10-5 M (Fig. 5A). Previous studies 354 
have shown that the SALMFamide neuropeptides S1 and S2 cause relaxation of apical muscle 355 
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preparations from Asterias rubens, which is closely related to A. amurensis (Melarange & Elphick 356 
2003). Therefore, we compared the bioactivity of SMP with S1 and S2 and found that the Emax for 357 
S1 and S2 at a concentration of 10-5 M were less than for SMP, 62.3±4.4 and 38.7±1.21, 358 
respectively (Fig. 5A). However, by comparison with S1 and S2, SMP was less effective as a 359 
relaxant of the apical muscle from A. amurensis (Fig. 5A) than from P. pectinifera (Fig. 2E). These 360 
findings indicate that SMP or a related peptide(s) exists in A. amurensis and that SMP-type 361 
peptides act as muscle relaxants throughout the Asteroidea. Accordingly, a cDNA encoding an 362 
SMP-type precursor was identified in A. rubens, comprising a 224-residue protein with a predicted 363 
21-residue signal peptide and eight copies of putative SMP-like peptides: four copies of the peptide 364 
FGGKGAFDPLSAGFTD, two copies of the peptide    FGGSRGAFDPLSAGFTD and one copy 365 
each of GFGMGAYDPLSAGFTD and SFVHGDFDPLSTGFVDGD (Fig. 5B and Figure S2, 366 
GenBank Accession number: KT870153). It is noteworthy that the C-terminal region of three of 367 
these peptides (DPLSAGFTD) is identical to the corresponding region of P. pectinifera SMP. 368 
 369 
Starfish SMP precursors are homologs of neuropeptide precursors that have been identified 370 
in other echinoderms 371 
To investigate relationships with neuropeptide precursors that have been in other animals, 372 
the P. pectinifera and A. rubens SMP precursor proteins were submitted as queries against the 373 
GenBank nr database using BLAST. The top two hits (XP_785647.1 and XP_003727926) were 374 
identified neuropeptide precursor proteins that have been described previously from the sea urchin 375 
Strongylocentrotus purpuratus and designated as Spnp6 and Spnp7, respectively (Rowe & Elphick 376 
2012). In Fig. 6, we show a multiple sequence alignment of the P. pectinifera SMP precursor, the A. 377 
rubens SMP-type precursor, Spnp6, Spnp7 and a homolog of Spnp7 that has been identified in the 378 
sea cucumber A. japonicus (Ajnp7, (Rowe et al. 2014)). Furthermore, alignment of the putative 379 
neuropeptides derived from the P. pectinifera SMP precursor, the A. rubens SMP-type precursor, 380 
Spnp6, Spnp7 and Ajnp7 (Fig. 7) reveals that the peptides have a number of features in common. 381 
These include two phenylalanine residues located at or near the N- and C-termini of the peptides as 382 
well as a conserved core region with the motif (D/E)-(P)-(L/M), structural characteristics that may 383 
be important for the bioactivity of these peptides.  384 
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Discussion 385 
 386 
 Here we have isolated a novel hexadecapeptide (FGKGGAYDPLSAGFTD) from starfish 387 
that acts as a muscle relaxant and which we have designated as starfish myorelaxant peptide or 388 
SMP. Previous studies have identified the SALMFamide neuropeptides S1 and S2 as muscle 389 
relaxants in starfish (Melarange & Elphick 2003; Melarange et al. 1999) and here the bioactivity of 390 
SMP, S1 and S2 as muscle relaxants were compared. When tested on three preparations from P. 391 
pectinifera (apical muscle, cardiac stomach and tube feet), SMP was more effective/potent than S1 392 
or S2. This finding is likely to be physiologically relevant with respect to S1 because we know that 393 
S1 occurs in the closely related species Patiria miniata. However, P. miniata does not contain S2 394 
and this species has instead an S2-like peptide (Elphick et al. 2013; Elphick et al. 2015). Therefore, 395 
the inferior bioactivity of S2 as a myorelaxant in P. pectinifera may in part be attributable to 396 
differences in peptide structure. Furthermore, analysis of the sequences of the two SALMFamide 397 
precursor proteins in P. miniata reveals that they comprise S1, the S2-like peptide and fourteen 398 
other SALMFamide-type peptides (Elphick et al. 2015; Elphick et al. 2013). So comparison of the 399 
effects of SMP with S1 or S2 tested in isolation does not reflect the physiological occurrence of 400 
“cocktails” of SALMFamides. Nevertheless, the superior bioactivity of SMP as a myorelaxant, 401 
compared to S1 and S2, in tests on muscle preparations from both P. pectinifera and Asterias 402 
amurensis clearly indicates that SMP is a physiologically important regulator of muscle relaxation 403 
in starfish.  404 
Analysis of the distribution of the expression of the SMP precursor in P. pectinifera using 405 
qPCR revealed a widespread pattern of expression, including all three neuromuscular preparations 406 
that SMP causes relaxation of in vitro – the apical muscle, cardiac stomach and tube feet. Likewise, 407 
immunocytochemical- and radioimmunoassay-based analysis of the distribution of S1 and S2 in A. 408 
rubens reveals a widespread pattern of expression (Elphick et al. 1995; Moore & Thorndyke 1993; 409 
Newman et al. 1995b; Newman et al. 1995a). Therefore, it is likely that SMP and SALMFamide 410 
neuropeptides act in concert as muscle relaxants to regulate a variety of physiological processes in 411 
starfish. For example, relaxing effects on the apical muscle in vivo may be associated with neural 412 
mechanisms that control changes in body posture, whereas relaxing effects on tube feet in vivo may 413 
be associated with locomotor activity. The relaxing action of SALMFamides on the cardiac 414 
stomach is thought be relevant to neural mechanisms controlling stomach eversion during feeding 415 
in starfish (Melarange et al. 1999) and this role may equally apply to the novel SMP neuropeptide 416 
identified here. Further insights into the physiological roles of SMP and other SMP-like peptides 417 
derived from the same precursor protein may be obtained by analysis of the distribution of these 418 
peptides at the cellular level. As highlighted above, detailed immunocytochemical analyses of the 419 
distribution of S1 and S2 in A. rubens have been reported previously (Elphick et al. 1995; Moore & 420 
Page 13 of 47 Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
14 
 
Thorndyke 1993; Newman et al. 1995b; Newman et al. 1995a) and it would be interesting to 421 
compare the distribution of SMP and SALMFamides using this approach. 422 
Comparative analysis of the sequence of SMP and the SMP precursor with neuropeptides 423 
and neuropeptide precursors that have been identified in other animals has revealed that SMP 424 
belongs to a bilaterian family of neuropeptides that includes molluscan pedal peptides (PP) and 425 
arthropodan orcokinins (OK). The occurrence of PP/OK-type peptides in echinoderms has been 426 
reported previously based on analysis of genome/transcriptome sequence data (Rowe & Elphick 427 
2012; Rowe et al. 2014) and in Fig. 6 and Fig. 7, respectively, we show alignments of SMP and the 428 
SMP precursor with related PP/OK-type neuropeptides and precursor proteins that have been 429 
identified in the sea urchin S. purpuratus and the sea cucumber A. japonicus. These alignments 430 
reveal conserved residues that may be important for the bioactivity of PP/OK-type peptides in 431 
echinoderms. In Fig. 8 we show an alignment of SMP and other representative echinoderm PP/OK-432 
type peptides with molluscan pedal peptides and arthropodan orcokinins. What this reveals is the 433 
conservation of hydrophobic residues, which are typically phenylalanine, proximal to or at the N- 434 
and C-termini of the peptides. This suggests that these evolutionarily conserved structural features 435 
are important for the bioactivity of PP/OK-type peptides in the Bilateria. However, the motif 436 
(D/E)-(P)-(L/M) that is a conserved feature of the core of echinoderm PP/OK-type peptides, 437 
including SMP (Fig. 7), is not seen in molluscan and arthropodan PP/OK-type peptides and 438 
therefore this may be a unique characteristic of echinoderm representatives of this neuropeptide 439 
family.   440 
With the identification of SMP as a member of the PP/OK-type family of neuropeptides, it 441 
is of interest to consider what is known about the physiological roles of these neuropeptides in 442 
other phyla. PP was originally discovered in the mollusc A. californica as a peptide that causes 443 
contraction of pedal muscles (Lloyd & Connolly 1989; Hall & Lloyd 1990); it also stimulates 444 
beating of cilia associated with the foot (Longley & Peterman 2013). OK was first isolated from 445 
neural extracts of the crayfish Orconectus limosus on account of its stimulatory effect on hindgut 446 
activity (Stangier et al. 1992). Subsequently, OK-type peptides have been identified in several 447 
arthropod species and found to have a variety of effects, including stimulation of the prothoracic 448 
gland and regulation of ecdysteroidogenesis in the silk moth Bombyx mori (Yamanaka et al. 2011) 449 
and regulation of circadian activity in the cockroach Leucophaea maderae (Hofer & Homberg 450 
2006; Soehler et al. 2011; Wei & Stengl 2011). Thus, in both molluscs and arthropods, PP/OK-type 451 
neuropeptides have stimulatory effects on the activity of muscle and other tissues. This contrasts 452 
with the inhibitory effect that SMP has in causing relaxation of muscle in starfish, as reported here. 453 
It will be interesting, therefore, to investigate in future studies if PP/OK-type peptides also act as 454 
muscle relaxants in other echinoderms or if this is a unique characteristic of PP/OK-type peptides 455 
in starfish. 456 
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Thus far, PP/OK-type peptides have not been identified in other deuterostomian phyla such 457 
as hemichordates, which are a sister clade to the echinoderms, or chordates. One possibility is that 458 
PP/OK-type peptides have been lost in hemichordates and chordates and the echinoderms are 459 
unique amongst the deuterostomes in retaining peptides belonging to this bilaterian neuropeptide 460 
family. Alternatively, the possibility remains that members of this neuropeptide family exist in 461 
hemichordates and chordates but their relationship with PP/OK-type peptides has not been 462 
observed due to sequence divergence. Addressing this issue would be facilitated if the receptors 463 
that mediate the effects of PP/OK-type peptides in echinoderms or in protostomes were identified, 464 
and therefore this represents an important objective for future research on PP/OK-type peptides. At 465 
the outset of this paper, we highlighted the variety of types of neuropeptides that have been 466 
identified as muscle relaxants in mammals and other vertebrates. Our discovery of SMP as a novel 467 
muscle relaxant in a deuterostomian invertebrate may provide a basis for discovery of 468 
evolutionarily related neuropeptides in vertebrates, with potential biomedical applications in 469 
humans.  470 
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Figure legends 609 
 610 
Fig. 1 The starfish Patiria pectinifera. The aboral side (A) and oral side (B) of an intact animal are 611 
illustrated. The position of the apical muscles on the inner surface of the aboral body wall of a 612 
dissected animal is shown in (C). An extract of P. pectinifera containing peptidic materials relaxed 613 
apical muscle that was pre-contracted with 1 μM acetylcholine (ACh); up and down arrows 614 
represent application of ACh and the extract, respectively (D). 615 
 616 
Fig. 2 Isolation, structure determination, and pharmacology of purified peptide. Peak A was 617 
isocratically eluted with 20 % acetonitrile/0.1 % TFA on RP-HPLC (A), and an aliquot of purified 618 
peak A caused relaxation of the apical muscle (B). Purified peak A was identified as a peptide 619 
comprised of sixteen amino acid residues with a molecular mass of 1601.72 Da, which we have 620 
named starfish myorelaxant peptide or SMP (C). Comparison of chromatographic properties of 621 
native SMP (N) and synthetic SMP (S) on RP-HPLC showed that native SMP and synthetic SMP 622 
with a free carboxy terminal have identical retention times on RP-HPLC (D). The concentration-623 
dependent relaxing activity of SMP on the apical muscle of P. pectinifera. SMP with free carboxyl 624 
terminus and amidated carboxy terminus is SMP (●) and SMPamide (○), respectively. The effects 625 
of S1 (▲) and S2 (△) from the starfish A. rubens and the molluscan neuropeptides FLRFamide (■) 626 
and FMRFamide (□) are shown to compare their activity with SMP. Each point represents the 627 
mean ± standard deviation determined from four separate experiments. The percentage relaxing 628 
activity was calculated by comparing each relaxation effect to the maximal contraction of the 629 
apical muscle by 1 μM ACh (D). 630 
 631 
Fig. 3 Precursor of starfish myorelaxant peptide (SMP) in Patiria pectinifera. The DNA sequence 632 
of a transcript (lowercase, 1682 bases) encoding the P. pectinifera SMP precursor (uppercase, 426 633 
amino acid residues) is shown. The predicted signal peptide, the purified mature SMP (SMPa), and 634 
three other variants (SMPb, [Met3]-SMPa; SMPc, [Met3, Glu16]-SMPa; SMPd, SMPa-related 635 
octadecapeptide) are shown in blue, red, pink, orange and purple, respectively, and putative dibasic 636 
cleavage sites (KR) are shown in green. The asterisk shows the position of the stop codon. The 637 
SMP precursor protein comprises twelve copies of SMP and seven copies of SMP-like peptides. 638 
 639 
Fig. 4 The expression levels for the SMP precursor transcript in various organs/tissues from P. 640 
pectinifera and the pharmacological effects of SMP on cardiac stomach and tube foot from P. 641 
pectinifera. Relative expression levels of SMP transcripts in each organ/tissue were normalized 642 
against the level of the EF1α gene as an internal control. Means and standard deviations (n=3) are 643 
shown. Bars with different letters indicate statistically significant differences between tissues 644 
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(p < 0.05) determined by one-way ANOVA followed by Duncan’s Multiple Range test (A). SMP 645 
caused concentration-dependent relaxation of the cardiac stomach (B) and tube foot (C) from P. 646 
pectinifera. The relaxing activity of SMP (●) was compared with S1 (▲) and S2 (△). Each point 647 
represents the mean ± standard deviation determined from four separate experiments. The 648 
percentage relaxing activity was calculated by comparing each relaxation effect to the maximal 649 
contraction of cardiac stomach caused by 10 μM carbacol and of tube foot caused by 30 mM high-650 
potassium ASW, respectively. 651 
 652 
Fig. 5 Pharmacological effect of SMP on apical muscle from Asterias amunensis and identification 653 
of an SMP-type precursor in Asterias rubens. (A). The concentration-dependent relaxing activity of 654 
SMP (●) compared with S1 (▲) and S2 (△) on the apical muscle of A. amurensis. Each point 655 
represents the mean ± standard deviation determined from four separate experiments. The 656 
percentage relaxing activity was calculated by comparing each relaxation effect to the maximal 657 
contraction of apical muscle caused by 1 μM ACh. (B) Amino acid sequence of a 224-residue 658 
SMP-type precursor protein identified in A. rubens, which comprises a predicted 21-residue signal 659 
peptide (blue) and eight copies of putative SMP-like peptides (red) and putative dibasic cleavage 660 
sites (KR, green). The sequence of the cDNA encoding this protein is shown in Supplementary 661 
Figure 2. 662 
 663 
Fig. 6 Multiple sequence alignment of the P. pectinifera SMP precursor with related neuropeptide 664 
precursors in other echinoderms. Highlighted red, green, blue, yellow and purple boxes represent 665 
multiple copies of neuropeptides separated by putative cleavage sites (KR or KK). All of the 666 
precursors contain multiple copies of related peptides: P. pectinifera SMP precursor contains 667 
twelve copies of SMP and seven copies of SMP-like peptides; A. rubens SMP precursor contains 668 
eight copies of SMP-like peptides; S. purpuratus neuropeptide precursor 6 (Spnp6) contains twenty 669 
one copies of nine SMP-like peptides; Spnp7 precursor contains ten copies of nine SMP-like 670 
peptides; A. japonicus neuropeptide precursor 7 (Ajnp7) contains six copies of five SMP-like 671 
peptides. The sequences of Spnp6, Spnp7 and Ajnp7 are from (Rowe & Elphick 2012; Rowe et al. 672 
2014). 673 
 674 
Fig. 7 Alignment of SMP (SMPa) with putative SMP-like neuropeptides derived from echinoderm 675 
SMP-type precursors: the starfish P. pectinifera and A. rubens; sea urchin S. purpuratus; sea 676 
cucumber A. japonicus. Conserved residues are highlighted in black and grey. 677 
 678 
Fig. 8 Alignment of echinoderm SMP-type peptides with protostomian pedal peptide 679 
(PP)/orcokinin(OK)-type peptides. The basic amino acids Lys, Arg, and His are shown in the black 680 
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with light grey highlighting, and the acidic residues Glu and Asp are shown in black with dark grey 681 
highlighting. All other amino acids are classified as hydrophobic (white with light grey 682 
highlighting) or hydrophilic (white with dark grey highlighting). Lower case “a” denotes a C-683 
terminal amide group. Species abbreviations and references: Pp, P. pectinifera; Ar, A. rubens; Sp, 684 
S. purpuratus (Reich et al. 2015); Aj, A. japonicas (Rowe & Elphick 2012; Du et al. 2012); Ac, 685 
Aplysia californica (Moroz et al. 2006); Pd, Platynereis dumerilii (Conzlmann et al. 2011); Ce, 686 
Caenorhabditis elegans; Pc, Procambrus clarkia (Yasuda-Kamatani & Yasuda 2000); Nv, 687 
Nasonia vitripennis.  688 
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Supporting information 689 
 690 
Supplementary Table legend 691 
 692 
Table S1 Primers used for RACE and RT-qPCR analysis of SMP precursor expression in P. 693 
pectinifera 694 
 695 
Supplementary Figure legends 696 
 697 
Figure S1 MALDI-TOF mass spectrum of purified peak A (A). Comparison of the 698 
chromatographic properties of synthetic SMP with a free carboxyl terminus (SMP) and SMP with 699 
an amidated carboxyl terminus (SMPamide) on RP-HPLC reveals that the two peptides elute at 700 
different retention times with isocratic 20% acetonitrile/0.1 % TFA (B). 701 
 702 
Figure S2 Precursor of starfish myoactive peptide (SMP)-type neuropeptides in Asterias rubens. 703 
The DNA sequence of a transcript (lowercase, 948 bases) encoding the A. rubens SMP-type 704 
precursor (uppercase, 224 amino acid residues) is shown. The sequences that were used to design 705 
primers for PCR amplification of the cDNA are underlined. The predicted signal peptide of the 706 
precursor protein is shown in blue and the eight putative mature neuropeptides are shown in red. 707 
Putative dibasic cleavage sites (KR) are shown in green and the asterisk shows the position of the 708 
stop codon.  709 
Page 24 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
25 
 
Table S1 Primers used for RACE and RT-qPCR analysis of SMP precursor expression in P. 710 
pectinifera 711 
Primers Sequence (5’-3’) Amplification 
SMP-3F TTYGGNAARGGNGGNGCNTAYGA 3’RACE 
SMP-3nF GNGCNTAYGAYCCNYTNWSNGCNG 3’nested RACE 
SMP-5R AGAATCGTCAATGGAAGTGTTCATATAGTCAGTGG 5’RACE 
SMP-5nR GGAGTTGGTATTGTCTGGATCTTCTTATCGG 5’nested RACE 
SMP RT-F GGT TTC CTA CAC GGA CCA GAC 
RT-qPCR 
SMP RT-R CCA CAA GGT GAC GGA AAG GG 
EF-1α RT-F TCA ACG ACT ACC AGC CCC TA 
RT-qPCR EF-1α RT-R TTC TTG CTA GCC TTC TGG GC 
 712 
  713 
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Graphical abstract 
 
Little is known about the molecular identity of neuropeptides that act as muscle relaxants in 
deuterostomian invertebrates (e.g. echinoderms) that are “evolutionary intermediates” of chordates 
and protostomes. In this study, a hexadecapeptide was identified from a starfish, Patiria pectinifera, 
and designated starfish myorelaxant peptide (SMP). The SMP precursor comprises 19 copies of SMP 
and related peptides and is widely expressed in P. pectinifera, including several neuromuscular 
organs. SMP causes relaxation of several muscle preparations from P. pectinifera and another starfish 
species, Asterias amurensis, indicating that SMP has a general physiological role as a muscle relaxant 
in starfish. Interestingly, comparison of the sequence of the SMP precursor with known neuropeptide 
precursors revealed that SMP belongs to a bilaterian family of neuropeptides that include molluscan 
pedal peptides (PP) and arthropodan orcokinins (OK). This is the first study to determine the function 
of a PP/OK-type peptide in a deuterostome. 
Page 36 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Page 37 of 47 Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 1  
216x208mm (300 x 300 DPI)  
 
 
Page 38 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 2  
286x305mm (300 x 300 DPI)  
 
 
Page 39 of 47 Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 3  
651x273mm (300 x 300 DPI)  
 
 
Page 40 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 4  
447x140mm (300 x 300 DPI)  
 
 
Page 41 of 47 Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 5  
179x227mm (300 x 300 DPI)  
 
 
Page 42 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 6  
422x228mm (300 x 300 DPI)  
 
 
Page 43 of 47 Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 7  
364x383mm (300 x 300 DPI)  
 
 
Page 44 of 47Journal of Neurochemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig. 8  
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